Ovarian hyperstimulation syndrom. Hyperstimulation of ovaries
Conditions
Interventions
Intervention 1: The first group treat with 0.5mg of Dostinex every day for seven days commencing on the day of oocyte retrival. Intervention 2: The second group treat with 75 mg of Quinagolid every
Treatment - Drugs
The first group treat with 0.5mg of Dostinex every day for seven days commencing on the day of oocyte retrival.
The second group treat with 75 mg of Quinagolid every day for 7 days commencing on the day of oocyte retrival.
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 20-40 years old patient; 20 oocytes when agonist GnRh start;risk of OHSS Exclusion criteria: metabolic dysfunction; hypertension; history of syncope; heart disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: 3 and 6 days after drug prescription. Method of measurement: Questionnaire.;Abdominal distention. Timepoint: 3 and 6 days after drug prescription. Method of measurement: Questionnaire and physical examination.;Hemoconcentration. Timepoint: 3 and 6 days after drug prescription. Method of measurement: Clinical lab.;Ascit. Timepoint: 3 and 6 days after drug prescription. Method of measurement: Sonography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Tap of ascit. Timepoint: 3 and 6 days after drug prescription. Method of measurement: paracentesis.;Hospitalization. Timepoint: 3 and 6 days after drug prescription. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Sadeghzadeh
Infertility & Reproductive Health Research Center,Shahid Beheshti University of Medical Sciences
Outcome results
None listed